{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:14Z","timestamp":1787026694619,"version":"build-2736575974"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00180","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T07:21:39Z","timestamp":1582874499000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["In vitro Activity of a New Fourth-Generation Cephalosporin, Cefoselis, Against Clinically Important Bacterial Pathogens in China"],"prefix":"10.3389","volume":"11","author":[{"given":"Jing-Wei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Rong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Meng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kudinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"B1","year":"2018","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing. 28th Ed. CLSI Supplement M100."},{"key":"B2","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1517\/14656566.2016.1154538","article-title":"Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.","volume":"17","author":"D\u2019Angelo","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8020052","article-title":"The continuing threat of methicillin-resistant Staphylococcus aureus.","volume":"8","author":"Gajdacs","year":"2019","journal-title":"Antibiotics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0732-8893(99)00131-5","article-title":"In-vitro activity of FK 037 (Cefoselis), a novel 4(th) generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates.","volume":"36","author":"Giamarellos-Bourboulis","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1093\/cid\/ciy657","article-title":"Current status and trends of antibacterial resistance in China.","volume":"67","author":"Hu","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1469-0691.1995.tb00018.x","article-title":"The comparative In Vitro activity of FK- 037 (Cefoselis), a new broad-spectrum cephalosporin.","volume":"1","author":"King","year":"1995","journal-title":"Clin. Microbiol. Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B8","first-page":"2006","article-title":"Multicenter, double- blind, randomized clinical trial of parenterally administered Cefoselis versus Cefepime for the treatment of acute bacterial infections.","volume":"18","author":"Liu","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2165\/11635660-000000000-00000","article-title":"Ceftaroline fosamil in the treatment of community- acquired bacterial pneumonia and acute bacterial skin and skin structure infections.","volume":"72","author":"Lodise","year":"2012","journal-title":"Drugs"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079782","article-title":"Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.","volume":"8","author":"Peng","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1093\/cid\/cit614","article-title":"Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.","volume":"58","author":"Rodvold","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens.","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/14787210.2018.1436966","article-title":"Management of infections caused by extended-spectrum beta-lactamase- producing Enterobacteriaceae: current evidence and future prospects.","volume":"16","author":"Sheu","year":"2018","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B14","author":"Tacconelli","year":"2017","journal-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ijantimicag.2010.09.001","article-title":"Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 study for monitoring antimicrobial resistance trends (SMART).","volume":"36","author":"Yang","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.11.012","article-title":"In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum beta- Lactamases in China.","volume":"45","author":"Yang","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1099\/jmm.0.059816-0","article-title":"A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.","volume":"62","author":"Yang","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijantimicag.2014.12.014","article-title":"A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.","volume":"45","author":"Zhang","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/AAC.00956-15","article-title":"Antimicrobial susceptibilities of aerobic and facultative gram-negative Bacilli from intra- abdominal infections in patients from seven regions in China in 2012 and 2013.","volume":"60","author":"Zhang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.diagmicrobio.2012.03.003","article-title":"Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the gram-positive CocciResistance surveillance program (2005-2010).","volume":"73","author":"Zhao","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T08:45:05Z","timestamp":1582879505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":20,"alternative-id":["10.3389\/fmicb.2020.00180"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00180","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"article-number":"180"}}